Home › Therapeutic areas › Oncology › Colorectal Cancer
Colorectal Cancer (15 companies)
Companies with an active program in Colorectal Cancer.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| ACTU | Actuate Therapeutics | Oncology | 1 | Phase 2 | 7 |
| ADAG | Adagene Inc. | Oncology | 1 | Phase 2 | 9 |
| AKTS | Aktis Oncology, Inc. | Oncology | 1 | Phase 1 | 9 |
| ARVN | ARVINAS, INC. | NeurologyOncology Rare | 1 | Approved | 15 |
| BBOT | BridgeBio Oncology Therapeutics, Inc. | Oncology | 2 | Phase 1 | 8 |
| CBIO | CRESCENT BIOPHARMA, INC. | Oncology | 1 | Phase 1 | 10 |
| CYDY | CytoDyn Inc. | Oncology | 1 | Phase 2 | 2 |
| CTMX | CytomX Therapeutics, Inc. | Oncology | 1 | Phase 1 | 3 |
| EXEL | EXELIXIS, INC. | Oncology | 1 | NDA Submitted | 2 |
| IBRX | ImmunityBio, Inc. | Infectious DiseaseOncology | 1 | Approved | 17 |
| KURA | Kura Oncology, Inc. | MetabolicOncology | 1 | Phase 1 | 9 |
| MAIA | MAIA Biotechnology, Inc. | Oncology | 1 | Phase 2 | 7 |
| PMVP | PMV Pharmaceuticals, Inc. | Oncology | 1 | Phase 2 | 7 |
| SMMT | Summit Therapeutics Inc. | Oncology | 1 | Phase 3 | 3 |
| VIR | Vir Biotechnology, Inc. | Infectious DiseaseOncology Rare | 2 | Phase 3 | 10 |
No companies match.